Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries

BMC Cardiovasc Disord. 2020 Jul 14;20(1):337. doi: 10.1186/s12872-020-01613-y.

Abstract

Background: High blood glucose impairs voltage-gated K+ (Kv) channel-mediated vasodilation in rat coronary artery smooth muscle cells (CSMCs) via oxidative stress. Advanced glycation end product (AGE) and receptor for AGE (RAGE) axis has been found to impair coronary dilation by reducing Kv channel activity in diabetic rat small coronary arteries (RSCAs). However, its underlying mechanism remain unclear. Here, we used isolated arteries and primary CSMCs to investigate the effect of AGE incubation on Kv channel-mediated coronary dilation and the possible involvement of peroxisome proliferators-activated receptor (PPAR) -γ pathway.

Methods: The RSCAs and primary CSMCs were isolated, cultured, and treated with bovine serum albumin (BSA), AGE-BSA, alagrebrium (ALA, AGE cross-linking breaker), pioglitazone (PIO, PPAR-γ activator) and/or GW9662 (PPAR-γ inhibitor). The groups were accordingly divided as control, BSA, AGE, AGE + ALA, AGE + PIO, or AGE + PIO + GW9662. Kv channel-mediated dilation was analyzed using wire myograph. Histology and immunohistochemistry of RSCAs were performed. Western blot was used to detect the protein expression of RAGE, major Kv channel subunits expressed in CSMCs (Kv1.2 and Kv1.5), PPAR-γ, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-2 (NOX-2).

Results: AGE markedly reduced Forskolin-induced Kv channel-mediated dilation of RSCAs by engaging with RAGE, and ALA or PIO significantly reversed the functional loss of Kv channel. In both RSCAs and CSMCs, AGE reduced Kv1.2/1.5 expression, increased RAGE and NOX-2 expression, and inhibited PPAR-γ expression, while ALA or PIO treatment partially reversed the inhibiting effects of AGE on Kv1.2/1.5 expression, accompanied by the downregulation of RAGE and decreased oxidative stress. Meanwhile, silencing of RAGE with siRNA remarkably alleviated the AGE-induced downregulation of Kv1.2/1.5 expression in CSMCs.

Conclusion: AGE reduces the Kv channel expression in CSMCs and further impairs the Kv channel-mediated dilation in RSCAs. The AGE/RAGE axis may enhance oxidative stress by inhibiting the downstream PPAR-γ pathway, thus playing a critical role in the dysfunction of Kv channels.

Keywords: Advanced glycation end product; Coronary dilation; PPAR-γ pathway; Smooth muscle cells; Voltage-gated K+ channel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / pharmacology
  • Animals
  • Cells, Cultured
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism
  • Glycation End Products, Advanced / pharmacology*
  • Kv1.2 Potassium Channel / genetics
  • Kv1.2 Potassium Channel / metabolism*
  • Kv1.5 Potassium Channel / genetics
  • Kv1.5 Potassium Channel / metabolism*
  • Male
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / metabolism
  • Oxidative Stress / drug effects
  • PPAR gamma / drug effects
  • PPAR gamma / metabolism*
  • Pioglitazone / pharmacology
  • Rats, Sprague-Dawley
  • Serum Albumin, Bovine / pharmacology*
  • Signal Transduction
  • Vasodilation / drug effects*

Substances

  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Glycation End Products, Advanced
  • Kcna2 protein, rat
  • Kcna5 protein, rat
  • Kv1.2 Potassium Channel
  • Kv1.5 Potassium Channel
  • PPAR gamma
  • PPAR gamma, rat
  • advanced glycation end products-bovine serum albumin
  • Serum Albumin, Bovine
  • Pioglitazone